Abstract 1764: Inhibition of R-spondin (RSPO) signaling reduces the growth of multiple human tumors
Austin Gurney(Australian Centre for Heart Health), Timothy Hoey, John Lewicki(OncoMed (United States)), Wan-Ching Yen(OncoMed (United States)), Marcus Fischer(St. Jude Children's Research Hospital), Janak Raval(OncoMed (United States)), Jennifer Cain(Gilead Sciences (United States)), May Ji(OncoMed (United States)), Ann M. Kapoun(OncoMed (United States)), Chris Bond(OncoMed (United States)), Chris Murriel(OncoMed (United States)), Min Wang(Central South University), Jalpa Shah(OncoMed (United States)), Fumiko Axelrod(OncoMed (United States)), Cécile Chartier(Io Therapeutics (United States))
Cited by 0
Related Papers
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780
Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
|Journal of Virology|1996|651
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
|Proceedings of the National Academy of Sciences|2012|630
Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
|PLoS ONE|2008|582
Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA
|Cell Death and Differentiation|2019|582